A.R.T. Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-19,009
Closed -$2.76M 1019
2019
Q4
$2.76M Buy
+19,009
New +$2.62M 0.14% 202
2019
Q3
Sell
-32,193
Closed -$3.68M 1770
2019
Q2
$3.68M Buy
32,193
+18,643
+138% +$2.18M 0.21% 108
2019
Q1
$1.68M Buy
13,550
+7,782
+135% +$884K 0.1% 297
2018
Q4
$581K Buy
+5,768
New +$649K 0.04% 661
2018
Q1
Sell
-11,948
Closed -$1.4M 1795
2017
Q4
$1.4M Buy
+11,948
New +$1.35M 0.06% 495
2017
Q2
Sell
-23,896
Closed -$2.83M 1770
2017
Q1
$2.83M Sell
23,896
-2,369
-9% -$269K 0.13% 211
2016
Q4
$2.63M Buy
+26,265
New +$2.82M 0.16% 183
2015
Q3
Sell
-52,740
Closed -$5.59M 1631
2015
Q2
$5.59M Buy
+52,740
New +$5.84M 0.19% 128
2014
Q4
Sell
-16,654
Closed -$1.63M 1691
2014
Q3
$1.63M Sell
16,654
-66,865
-80% -$6.58M 0.08% 354
2014
Q2
$8.42M Buy
83,519
+80,934
+3,131% +$7.9M 0.44% 26
2014
Q1
$237K Buy
+2,585
New +$238K 0.01% 1090
2013
Q3
Sell
-12,437
Closed -$904K 1526
2013
Q2
$904K Buy
+12,437
New +$930K 0.03% 668

Other funds holding ZBH

A.R.T. Advisors's ZBH Position: Q1 2020 in Review

A.R.T. Advisors sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 19,009 shares — an estimated $2.76M sold.

A.R.T. Advisors first reported a position in ZBH in Q2 2013 and held it in 12 quarters. The position peaked at $8.42M in Q2 2014. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

  • A.R.T. Advisors reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 19,009 Zimmer Biomet shares in Q1 2020, an estimated $2.76M.
  • A.R.T. Advisors first reported a position in Zimmer Biomet in Q2 2013 and held it in 12 quarters.
  • A.R.T. Advisors's Zimmer Biomet position peaked at $8.42M in Q2 2014.
  • 883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.